Joint effects of C-reactive protein and other risk factors on acute coronary events

被引:49
作者
Kervinen, H
Palosuo, T
Manninen, V
Tenkanen, L
Vaarala, O
Mänttäri, M
机构
[1] Hyvinkoo Hosp, Dept Med, Hyvinkaa 05850, Finland
[2] Natl Publ Hlth Inst, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland
关键词
D O I
10.1067/mhj.2001.113572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Elevated serum C-reactive protein (CRP) is a predictor of coronary heart disease in population samples. We studied the contribution of the simultaneous presence (joint effects) of elevated CRP and the classic as well as some new risk factors on acute coronary events. Methods With a nested case-control design and logistic regression analyses, we measured baseline and pre-event CRP levels in patients who had myocardial infarction or coronary death (cases) during an 8.5-year follow-up in the Helsinki Heart Study, a coronary primary prevention trial in dyslipidemic middle-aged men. The control patients were participants remaining Free of coronary events. Results Baseline and pre-event CRP levels were higher in cases than in control patients (4.4 vs 2.0 mg/L, P < .001 and 6.0 vs 3.6 mg/L, P < .001). The relative risk attributed to elevated CRP was 40% higher with chronic elevation (odds ratio [OR], 3.34) compared with high baseline (OR, 2.24) or pre-event (OR, 2.26) level only. Hypertension, low high-density lipoprotein cholesterol, and high leukocyte count increased the risk only marginally without simultaneous occurrence of high CRP, whereas the joint effects of CRP and these classic risk factors suggested additive effects on coronary risk. In contrast, high levels of immunoglobulin G-class antibodies to oxidized low-density lipoprotein and antiprothrombin antibodies as well as high total immunoglobulin G level increased the risk irrespective of CRP. Conclusions Elevated CRP enhances the risks attributed to classic coronary risk factors.
引用
收藏
页码:580 / 585
页数:6
相关论文
共 27 条
[1]  
CASTELL JV, 1989, ANN NY ACAD SCI, V557, P87
[2]  
Cortellaro M, 2000, THROMB HAEMOSTASIS, V83, P549
[3]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[4]  
HANSSON GK, 1989, AM J PATHOL, V135, P169
[5]   THE HELSINKI-HEART-STUDY - CORONARY HEART-DISEASE INCIDENCE DURING AN EXTENDED FOLLOW-UP [J].
HEINONEN, OP ;
HUTTUNEN, JK ;
MANNINEN, V ;
MANTTARI, M ;
KOSKINEN, P ;
TENKANEN, L ;
FRICK, MH .
JOURNAL OF INTERNAL MEDICINE, 1994, 235 (01) :41-49
[6]   Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease [J].
Holvoet, P ;
Vanhaecke, J ;
Janssens, S ;
Van de Werf, F ;
Collen, D .
CIRCULATION, 1998, 98 (15) :1487-1494
[7]   Mast cell infiltration in acute coronary syndromes: Implications for plaque rupture [J].
Kaartinen, M ;
Van der Wal, AC ;
Van der Loos, CM ;
Piek, JJ ;
Koch, KT ;
Becker, AE ;
Kovanen, PT .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :606-612
[8]   C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men -: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 [J].
Koenig, W ;
Sund, M ;
Fröhlich, M ;
Fischer, HG ;
Löwel, H ;
Döring, A ;
Hutchinson, WL ;
Pepys, MB .
CIRCULATION, 1999, 99 (02) :237-242
[9]   Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M [J].
Kovanen, PT ;
Mänttäri, M ;
Palosuo, T ;
Manninen, V ;
Aho, K .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (13) :1434-1439
[10]  
Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963